GENERAL ELECTRIC CO — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that GENERAL ELECTRIC CO filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $45.86B | Jan 29, 2026 |
| FY2024 | Dec 31, 2024 | $10.81B | Feb 3, 2025 |
| FY2024 | Sep 30, 2024 | $9.84B | Feb 3, 2025 |
| FY2024 | Jun 30, 2024 | $9.09B | Feb 3, 2025 |
| FY2024 | Mar 31, 2024 | $8.96B | Feb 3, 2025 |
| FY2024 | Dec 31, 2023 | $9.46B | Feb 3, 2025 |
| FY2024 | Sep 30, 2023 | $9.30B | Feb 3, 2025 |
| FY2024 | Jun 30, 2023 | $8.76B | Feb 3, 2025 |
| FY2024 | Mar 31, 2023 | $7.84B | Feb 3, 2025 |
| FY2023 | Dec 31, 2022 | $16.83B | Feb 2, 2024 |
Revenue
Revenue recognized from contracts with customers under ASC 606, excluding taxes collected on behalf of government authorities. This is the primary revenue concept for many companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | $9.88B | Feb 3, 2025 |
| FY2024 | Sep 30, 2024 | $8.94B | Feb 3, 2025 |
| FY2024 | Jun 30, 2024 | $8.22B | Feb 3, 2025 |
| FY2024 | Mar 31, 2024 | $8.08B | Feb 3, 2025 |
| FY2024 | Dec 31, 2023 | $8.55B | Feb 3, 2025 |
| FY2024 | Sep 30, 2023 | $8.46B | Feb 3, 2025 |
| FY2024 | Jun 30, 2023 | $7.91B | Feb 3, 2025 |
| FY2024 | Mar 31, 2023 | $7.04B | Feb 3, 2025 |
| FY2023 | Dec 31, 2022 | $16.05B | Feb 2, 2024 |
| FY2023 | Sep 30, 2022 | $13.83B | Feb 2, 2024 |
Revenue (Net Sales)
Net sales revenue — gross revenue less returns, allowances, and discounts. Used by many manufacturers and retailers as the primary top-line figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2017 | Dec 31, 2017 | $113.19B | Feb 23, 2018 |
| FY2016 | Dec 31, 2016 | $30.35B | Feb 24, 2017 |
| FY2016 | Sep 30, 2016 | $26.93B | Feb 24, 2017 |
| FY2016 | Jun 30, 2016 | $28.15B | Feb 24, 2017 |
| FY2016 | Mar 31, 2016 | $25.41B | Feb 24, 2017 |
| FY2016 | Dec 31, 2015 | $30.61B | Feb 24, 2017 |
| FY2016 | Sep 30, 2015 | $25.61B | Feb 24, 2017 |
| FY2016 | Jun 30, 2015 | $26.14B | Feb 24, 2017 |
| FY2016 | Mar 31, 2015 | $23.84B | Feb 24, 2017 |
| FY2016 | Dec 31, 2014 | $106.76B | Feb 24, 2017 |
Gross Profit
Revenue minus the cost of goods sold (COGS). Gross profit shows how much revenue remains to cover operating expenses, R&D, and administrative costs before calculating operating income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2016 | Dec 31, 2016 | $7.03B | Feb 24, 2017 |
| FY2016 | Sep 30, 2016 | $6.39B | Feb 24, 2017 |
| FY2016 | Jun 30, 2016 | $6.19B | Feb 24, 2017 |
| FY2016 | Mar 31, 2016 | $5.52B | Feb 24, 2017 |
| FY2016 | Dec 31, 2015 | $7.56B | Feb 24, 2017 |
| FY2016 | Sep 30, 2015 | $6.28B | Feb 24, 2017 |
| FY2016 | Jun 30, 2015 | $6.03B | Feb 24, 2017 |
| FY2016 | Mar 31, 2015 | $5.51B | Feb 24, 2017 |
| FY2012 | Dec 31, 2012 | $8.24B | Feb 26, 2013 |
| FY2012 | Sep 30, 2012 | $6.03B | Feb 26, 2013 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $8.70B | Jan 29, 2026 |
| FY2024 | Dec 31, 2024 | $1.90B | Feb 3, 2025 |
| FY2024 | Sep 30, 2024 | $1.85B | Feb 3, 2025 |
| FY2024 | Jun 30, 2024 | $1.27B | Feb 3, 2025 |
| FY2024 | Mar 31, 2024 | $1.54B | Feb 3, 2025 |
| FY2024 | Dec 31, 2023 | $1.59B | Feb 3, 2025 |
| FY2024 | Sep 30, 2023 | $352.00M | Feb 3, 2025 |
| FY2024 | Jun 30, 2023 | $33.00M | Feb 3, 2025 |
| FY2024 | Mar 31, 2023 | $7.51B | Feb 3, 2025 |
| FY2023 | Dec 31, 2022 | $2.20B | Feb 2, 2024 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2012 | Dec 31, 2012 | $22.89B | Feb 26, 2013 |
| FY2011 | Dec 31, 2011 | $20.57B | Feb 24, 2012 |
| FY2011 | Dec 31, 2010 | $17.25B | Feb 24, 2012 |
| FY2011 | Dec 31, 2009 | $15.62B | Feb 24, 2012 |
| FY2011 | Dec 31, 2008 | $22.20B | Feb 24, 2012 |
| FY2011 | Dec 31, 2007 | $25.61B | Feb 24, 2012 |
R&D Expense
Spending on research and development activities — developing new products, improving existing ones, or conducting basic research. High R&D relative to revenue is common in technology and pharmaceutical companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.58B | Jan 29, 2026 |
| FY2025 | Dec 31, 2024 | $1.29B | Jan 29, 2026 |
| FY2025 | Dec 31, 2023 | $1.01B | Jan 29, 2026 |
| FY2024 | Dec 31, 2022 | $808.00M | Feb 3, 2025 |
| FY2023 | Dec 31, 2021 | $1.68B | Feb 2, 2024 |
| FY2022 | Dec 31, 2020 | $2.57B | Feb 10, 2023 |
| FY2021 | Dec 31, 2019 | $3.12B | Feb 11, 2022 |
| FY2020 | Dec 31, 2018 | $3.42B | Feb 12, 2021 |
| FY2018 | Dec 31, 2017 | $5.50B | Feb 26, 2019 |
| FY2018 | Dec 31, 2016 | $5.44B | Feb 26, 2019 |
SG&A Expense
Selling, general, and administrative expenses — the overhead costs of running the business, including salaries, marketing, legal fees, and corporate office costs. Excludes COGS and R&D.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $4.09B | Jan 29, 2026 |
| FY2025 | Dec 31, 2024 | $4.44B | Jan 29, 2026 |
| FY2025 | Dec 31, 2023 | $4.05B | Jan 29, 2026 |
| FY2024 | Dec 31, 2022 | $3.67B | Feb 3, 2025 |
| FY2023 | Dec 31, 2021 | $8.18B | Feb 2, 2024 |
| FY2022 | Dec 31, 2020 | $12.63B | Feb 10, 2023 |
| FY2021 | Dec 31, 2019 | $13.81B | Feb 11, 2022 |
| FY2020 | Dec 31, 2018 | $14.64B | Feb 12, 2021 |
| FY2019 | Dec 31, 2017 | $14.26B | Feb 24, 2020 |
| FY2018 | Dec 31, 2016 | $17.76B | Feb 26, 2019 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $8.54B | Jan 29, 2026 |
| FY2025 | Dec 31, 2024 | $4.71B | Jan 29, 2026 |
| FY2025 | Dec 31, 2023 | $5.19B | Jan 29, 2026 |
| FY2024 | Dec 31, 2022 | $5.92B | Feb 3, 2025 |
| FY2023 | Dec 31, 2021 | $3.48B | Feb 2, 2024 |
| FY2022 | Dec 31, 2020 | $3.57B | Feb 10, 2023 |
| FY2021 | Dec 31, 2019 | $8.73B | Feb 11, 2022 |
| FY2020 | Dec 31, 2018 | $4.98B | Feb 12, 2021 |
| FY2019 | Dec 31, 2017 | $6.55B | Feb 24, 2020 |
| FY2018 | Dec 31, 2016 | $1.16B | Feb 26, 2019 |
Capital Expenditures (Capex)
Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2022 | Dec 31, 2022 | $1.37B | Feb 10, 2023 |
| FY2022 | Dec 31, 2021 | $1.25B | Feb 10, 2023 |
| FY2022 | Dec 31, 2020 | $1.58B | Feb 10, 2023 |
| FY2021 | Dec 31, 2019 | $2.22B | Feb 11, 2022 |
| FY2020 | Dec 31, 2018 | $6.63B | Feb 12, 2021 |
| FY2019 | Dec 31, 2017 | $6.64B | Feb 24, 2020 |
| FY2018 | Dec 31, 2016 | $7.20B | Feb 26, 2019 |
| FY2017 | Dec 31, 2015 | $7.31B | Feb 23, 2018 |
| FY2016 | Dec 31, 2014 | $7.13B | Feb 24, 2017 |
| FY2015 | Dec 31, 2013 | $6.75B | Feb 26, 2016 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $130.17B | Jan 29, 2026 |
| FY2025 | Dec 31, 2024 | $123.14B | Jan 29, 2026 |
| FY2024 | Dec 31, 2023 | $173.30B | Feb 3, 2025 |
| FY2023 | Dec 31, 2022 | $188.85B | Feb 2, 2024 |
| FY2022 | Dec 31, 2021 | $198.87B | Feb 10, 2023 |
| FY2021 | Dec 31, 2020 | $256.21B | Feb 11, 2022 |
| FY2020 | Dec 31, 2019 | $265.18B | Feb 12, 2021 |
| FY2019 | Dec 31, 2018 | $311.07B | Feb 24, 2020 |
| FY2018 | Dec 31, 2017 | $369.25B | Feb 26, 2019 |
| FY2018 | Dec 31, 2016 | $359.12B | Feb 26, 2019 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $111.27B | Jan 29, 2026 |
| FY2025 | Dec 31, 2024 | $103.58B | Jan 29, 2026 |
| FY2024 | Dec 31, 2023 | $144.70B | Feb 3, 2025 |
| FY2023 | Dec 31, 2022 | $153.94B | Feb 2, 2024 |
| FY2022 | Dec 31, 2021 | $157.26B | Feb 10, 2023 |
| FY2021 | Dec 31, 2020 | $219.14B | Feb 11, 2022 |
| FY2020 | Dec 31, 2019 | $235.32B | Feb 12, 2021 |
| FY2019 | Dec 31, 2018 | $259.59B | Feb 24, 2020 |
| FY2018 | Dec 31, 2017 | $292.36B | Feb 26, 2019 |
| FY2017 | Dec 31, 2016 | $284.67B | Feb 23, 2018 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $18.68B | Jan 29, 2026 |
| FY2025 | Dec 31, 2024 | $19.34B | Jan 29, 2026 |
| FY2024 | Dec 31, 2023 | $27.40B | Feb 3, 2025 |
| FY2023 | Dec 31, 2022 | $33.70B | Feb 2, 2024 |
| FY2022 | Dec 31, 2021 | $40.31B | Feb 10, 2023 |
| FY2021 | Dec 31, 2020 | $35.55B | Feb 11, 2022 |
| FY2021 | Dec 31, 2019 | $28.32B | Feb 11, 2022 |
| FY2020 | Dec 31, 2018 | $30.98B | Feb 12, 2021 |
| FY2019 | Dec 31, 2017 | $56.03B | Feb 24, 2020 |
| FY2018 | Dec 31, 2016 | $70.16B | Feb 26, 2019 |
Goodwill
An intangible asset representing the premium paid above fair value when acquiring another company. A large goodwill balance signals a history of acquisitions at premium prices.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $9.06B | Jan 29, 2026 |
| FY2025 | Dec 31, 2024 | $8.54B | Jan 29, 2026 |
| FY2025 | Dec 31, 2023 | $8.95B | Jan 29, 2026 |
| FY2024 | Dec 31, 2022 | $8.84B | Feb 3, 2025 |
| FY2023 | Dec 31, 2021 | $13.30B | Feb 2, 2024 |
| FY2022 | Dec 31, 2020 | $25.52B | Feb 10, 2023 |
| FY2021 | Dec 31, 2019 | $25.90B | Feb 11, 2022 |
| FY2020 | Dec 31, 2018 | $33.97B | Feb 12, 2021 |
| FY2019 | Dec 31, 2017 | $58.82B | Feb 24, 2020 |
| FY2018 | Dec 31, 2016 | $70.44B | Feb 26, 2019 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $87.66B | Jan 29, 2026 |
| FY2025 | Dec 31, 2024 | $80.49B | Jan 29, 2026 |
| FY2024 | Dec 31, 2023 | $86.55B | Feb 3, 2025 |
| FY2023 | Dec 31, 2022 | $82.98B | Feb 2, 2024 |
| FY2022 | Dec 31, 2021 | $85.11B | Feb 10, 2023 |
| FY2021 | Dec 31, 2020 | $92.25B | Feb 11, 2022 |
| FY2020 | Dec 31, 2019 | $87.73B | Feb 12, 2021 |
| FY2019 | Dec 31, 2018 | $93.11B | Feb 24, 2020 |
| FY2018 | Dec 31, 2017 | $117.25B | Feb 26, 2019 |
| FY2017 | Dec 31, 2016 | $139.53B | Feb 23, 2018 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2017 | Dec 31, 2017 | $43.30B | Feb 23, 2018 |
| FY2017 | Dec 31, 2016 | $48.13B | Feb 23, 2018 |
| FY2017 | Dec 31, 2015 | $70.48B | Feb 23, 2018 |
| FY2011 | Dec 31, 2011 | $84.50B | Feb 24, 2012 |
| FY2011 | Dec 31, 2010 | $78.94B | Feb 24, 2012 |
| FY2009 | Dec 31, 2009 | $72.26B | Feb 19, 2010 |
| FY2009 | Dec 31, 2008 | $48.19B | Feb 19, 2010 |
| FY2009 | Dec 31, 2007 | $15.73B | Feb 19, 2010 |
Long-Term Debt
Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $20.47B | Jan 29, 2026 |
| FY2024 | Dec 31, 2024 | $19.27B | Feb 3, 2025 |
| FY2023 | Dec 31, 2023 | $20.86B | Feb 2, 2024 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 8 | Jan 29, 2026 |
| FY2024 | Dec 31, 2024 | 1 | Feb 3, 2025 |
| FY2024 | Sep 30, 2024 | 1 | Feb 3, 2025 |
| FY2024 | Jun 30, 2024 | 1 | Feb 3, 2025 |
| FY2024 | Mar 31, 2024 | 1 | Feb 3, 2025 |
| FY2024 | Dec 31, 2023 | 1 | Feb 3, 2025 |
| FY2024 | Sep 30, 2023 | 0 | Feb 3, 2025 |
| FY2024 | Jun 30, 2023 | 0 | Feb 3, 2025 |
| FY2024 | Mar 31, 2023 | 6 | Feb 3, 2025 |
| FY2023 | Dec 31, 2022 | 1 | Feb 2, 2024 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 8 | Jan 29, 2026 |
| FY2024 | Dec 31, 2024 | 1 | Feb 3, 2025 |
| FY2024 | Sep 30, 2024 | 1 | Feb 3, 2025 |
| FY2024 | Jun 30, 2024 | 1 | Feb 3, 2025 |
| FY2024 | Mar 31, 2024 | 1 | Feb 3, 2025 |
| FY2024 | Dec 31, 2023 | 1 | Feb 3, 2025 |
| FY2024 | Sep 30, 2023 | 0 | Feb 3, 2025 |
| FY2024 | Jun 30, 2023 | 0 | Feb 3, 2025 |
| FY2024 | Mar 31, 2023 | 6 | Feb 3, 2025 |
| FY2023 | Dec 31, 2022 | 1 | Feb 2, 2024 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 1.05B | Jan 29, 2026 |
| FY2025 | Dec 31, 2024 | 1.07B | Jan 29, 2026 |
| FY2024 | Dec 31, 2023 | 1.09B | Feb 3, 2025 |
| FY2023 | Dec 31, 2022 | 1.09B | Feb 2, 2024 |
| FY2022 | Dec 31, 2021 | 1.10B | Feb 10, 2023 |
| FY2021 | Dec 31, 2020 | 1.10B | Feb 11, 2022 |
| FY2020 | Dec 31, 2019 | 8.74B | Feb 12, 2021 |
| FY2019 | Dec 31, 2018 | 8.70B | Feb 24, 2020 |
| FY2018 | Dec 31, 2017 | 8.68B | Feb 26, 2019 |
| FY2018 | Dec 31, 2016 | 8.74B | Feb 26, 2019 |